Transactions: Healthcare
Filter
Directed share issue in CELLINK AB (SE) — SEK 1.5 billion
Senior unsecured convertible bond issue by CELLINK AB (SE) — SEK 1.5 billion
Directed share issue in Oncopeptides AB (SE) — SEK 1,106 million
Directed share issue in Nordic Nanovector ASA (NO) — NOK 361 million
Public offer to the shareholders of Recipharm AB – SEK 25.0 billion
Directed share issue in Paxman AB (SE) — SEK 60 million
Private placement in Devyser Diagnostics AB (SE) — SEK 130 million
Rights issue in InDex Pharmaceuticals Holding AB (SE) — SEK 533 million
Private placement in Dignio AS (NO) — NOK 85 million
Acquisition of Sanos Group by Investcorp – Amount not disclosed